Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TOUCH Project: Reducing Distress and Promoting Quality of Life Via Caregiver Massage of Children Undergoing Treatment for Cancer

NCT01053494 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT01053494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01053494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TOUCH Project: Reducing Distress and Promoting Quality of Life Via Caregiver Massage of Children Undergoing Treatment for Cancer
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2010
Completion date
February 29, 2012
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accelerated phase chronic myelogenous leukemia, acute undifferentiated leukemia, angioimmunoblastic t-cell lymphoma, atypical chronic myeloid leukemia, bcr-abl1 negative, blastic phase chronic myelogenous leukemia, burkitt lymphoma, childhood acute lymphoblastic leukemia in remission, childhood acute myeloid leukemia in remission, childhood chronic myelogenous leukemia, childhood diffuse large cell lymphoma, childhood grade iii lymphomatoid granulomatosis, childhood immunoblastic large cell lymphoma, childhood myelodysplastic syndromes, childhood nasal type extranodal nk/t-cell lymphoma, chronic eosinophilic leukemia, chronic myelomonocytic leukemia, chronic neutrophilic leukemia, chronic phase chronic myelogenous leukemia, contiguous stage ii mantle cell lymphoma, cutaneous b-cell non-hodgkin lymphoma, essential thrombocythemia, extramedullary plasmacytoma, intraocular lymphoma, isolated plasmacytoma of bone, juvenile myelomonocytic leukemia, mast cell leukemia, meningeal chronic myelogenous leukemia, noncontiguous stage ii mantle cell lymphoma, polycythemia vera, post-transplant lymphoproliferative disorder, primary myelofibrosis, primary systemic amyloidosis, progressive hairy cell leukemia, initial treatment, prolymphocytic leukemia, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, recurrent childhood anaplastic large cell lymphoma, recurrent childhood grade iii lymphomatoid granulomatosis, recurrent childhood large cell lymphoma, recurrent childhood lymphoblastic lymphoma, recurrent childhood small noncleaved cell lymphoma, recurrent cutaneous t-cell non-hodgkin lymphoma, recurrent mycosis fungoides/sezary syndrome, recurrent/refractory childhood hodgkin lymphoma, refractory chronic lymphocytic leukemia, refractory hairy cell leukemia, refractory multiple myeloma, relapsing chronic myelogenous leukemia, secondary acute myeloid leukemia, stage 0 chronic lymphocytic leukemia, stage i childhood anaplastic large cell lymphoma, stage i childhood hodgkin lymphoma, stage i childhood large cell lymphoma, stage i childhood lymphoblastic lymphoma, stage i childhood small noncleaved cell lymphoma, stage i chronic lymphocytic leukemia, stage i cutaneous t-cell non-hodgkin lymphoma, stage i multiple myeloma, stage i mycosis fungoides/sezary syndrome, stage ii childhood anaplastic large cell lymphoma, stage ii childhood hodgkin lymphoma, stage ii childhood large cell lymphoma, stage ii childhood lymphoblastic lymphoma, stage ii childhood small noncleaved cell lymphoma, stage ii chronic lymphocytic leukemia, stage ii cutaneous t-cell non-hodgkin lymphoma, stage ii multiple myeloma, stage ii mycosis fungoides/sezary syndrome, stage iii childhood anaplastic large cell lymphoma, stage iii childhood hodgkin lymphoma, stage iii childhood large cell lymphoma, stage iii childhood lymphoblastic lymphoma, stage iii childhood small noncleaved cell lymphoma, stage iii chronic lymphocytic leukemia, stage iii cutaneous t-cell non-hodgkin lymphoma, stage iii multiple myeloma, stage iii mycosis fungoides/sezary syndrome, stage iv childhood anaplastic large cell lymphoma, stage iv childhood hodgkin lymphoma, stage iv childhood large cell lymphoma, stage iv childhood lymphoblastic lymphoma, stage iv childhood small noncleaved cell lymphoma, stage iv chronic lymphocytic leukemia, stage iv cutaneous t-cell non-hodgkin lymphoma, stage iv mycosis fungoides/sezary syndrome, t-cell large granular lymphocyte leukemia, unspecified childhood solid tumor, protocol specific